Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Vorinostat in Children [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating vorinostat in pediatric patients with relapsed solid tumors, lymphoma, or leukemia.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
The PENELOPE observational study, which examined prophylaxis and treatment of arterial and venous thromboembolism in patients with hematolog…
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 trial of non-myeloablative HLA-mismatched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 study of non-Myeloablative HLA-matched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was terminat…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]
Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas [Phase 2]
This document provides an update on a Phase 2 trial evaluating two dosing schedules of perifosine in patients with solid tumors or lymphomas…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of NC-4016 in patients with advanced solid tumors or lymphoma has completed enrollment and the trial status is reported as com…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Y-90 ibritumomab tiuxetan with rituximab for relapsed or refractory diffuse large B-cell non-Hodgkin's lym…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial update involving a monoclonal antibody therapy for lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT [Phase 2]
Phase 2 trial evaluating post-transplant cyclophosphamide as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma [Phase 1]
Phase 1 clinical trial update for DT2219ARL in relapsed or refractory CD19+/CD22+ B-lineage leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [NA]
This clinical trial update reports completion of a study evaluating chemotherapy and total-body irradiation followed by donor umbilical cord…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma [Phase 1]
This document reports the completion of a Phase 1 trial of NPI-0052 in patients with advanced solid tumor malignancies or refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax [Phase 1]
Phase 1 trial update evaluating the effect of rifampin on navitoclax metabolism; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma [Phase 1]
Open-label Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of GSK1120212 (trametinib) in subjects with solid tum…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab in elderly patients with re…